Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M A Pfaller

Showing results (441-450 of 542) with videos related to

Pageof 55
Sort By:
Microbial Drug Resistance (Larchmont, N.Y.)|January 6, 2001
Genetic relatedness of multidrug-resistant, methicillin (oxacillin)-resistant Staphylococcus aureus bloodstream isolates from SENTRY Antimicrobial Resistance Surveillance Centers worldwide, 1998D J Diekema, M A Pfaller, J Turnidge, et al.
Diagnostic Microbiology and Infectious Disease|January 1, 1993
Molecular epidemiology and antimicrobial susceptibility testing. Testing of quinolone-resistant Staphylococcus aureus strains isolated in BrazilJ N Rodrigues, J L Amaral, I L Leme, et al.
The Journal of Pediatrics|March 1, 1992
Outbreak of Candida bloodstream infections associated with retrograde medication administration in a neonatal intensive care unitR J Sherertz, K S Gledhill, K D Hampton, et al.
European Journal of Epidemiology|November 1, 1993
In vitro activity of ceftriaxone and other cephalosporins against 602 clinical isolates of staphylococci from geographically diverse medical centersM A Pfaller, A L Barry, L D Sabath, et al.
Journal of Clinical Microbiology|May 6, 2005
Global trends in the antifungal susceptibility of Cryptococcus neoformans (1990 to 2004)M A Pfaller, S A Messer, L Boyken, et al.
Antimicrobial Agents and Chemotherapy|December 3, 1998
In vitro susceptibilities of Candida bloodstream isolates to the new triazole antifungal agents BMS-207147, Sch 56592, and voriconazoleM A Pfaller, S A Messer, R J Hollis, et al.
International Journal of Antimicrobial Agents|April 8, 2000
Trends in antimicrobial susceptibility of bacterial pathogens isolated from patients with bloodstream infections in the USA, Canada and Latin America. SENTRY Participants GroupD J Diekema, M A Pfaller, R N Jones, et al.
American Journal of Obstetrics and Gynecology|October 18, 2000
Group B streptococci causing neonatal bloodstream infection: antimicrobial susceptibility and serotyping results from SENTRY centers in the Western HemisphereJ I Andrews, D J Diekema, S K Hunter, et al.
Diagnostic Microbiology and Infectious Disease|August 1, 1988
Multicenter in vitro evaluation of lomefloxacin (NY-198, SC-47111), including tests against nearly 7,000 bacterial isolates and preliminary recommendations for susceptibility testingR N Jones, K E Aldridge, A L Barry, et al.
Journal of Clinical Microbiology|November 28, 2002
Molecular epidemiology of extended-spectrum beta-lactamase-producing, fluoroquinolone-resistant isolates of Klebsiella pneumoniae in TaiwanW-L Yu, R N Jones, R J Hollis, et al.
Pageof 55

Showing results (441-450 of 542) with videos related to

Sort By:
Pageof 55
Microbial Drug Resistance (Larchmont, N.Y.)|January 6, 2001
Genetic relatedness of multidrug-resistant, methicillin (oxacillin)-resistant Staphylococcus aureus bloodstream isolates from SENTRY Antimicrobial Resistance Surveillance Centers worldwide, 1998D J Diekema, M A Pfaller, J Turnidge, et al.
Diagnostic Microbiology and Infectious Disease|January 1, 1993
Molecular epidemiology and antimicrobial susceptibility testing. Testing of quinolone-resistant Staphylococcus aureus strains isolated in BrazilJ N Rodrigues, J L Amaral, I L Leme, et al.
The Journal of Pediatrics|March 1, 1992
Outbreak of Candida bloodstream infections associated with retrograde medication administration in a neonatal intensive care unitR J Sherertz, K S Gledhill, K D Hampton, et al.
European Journal of Epidemiology|November 1, 1993
In vitro activity of ceftriaxone and other cephalosporins against 602 clinical isolates of staphylococci from geographically diverse medical centersM A Pfaller, A L Barry, L D Sabath, et al.
Journal of Clinical Microbiology|May 6, 2005
Global trends in the antifungal susceptibility of Cryptococcus neoformans (1990 to 2004)M A Pfaller, S A Messer, L Boyken, et al.
Antimicrobial Agents and Chemotherapy|December 3, 1998
In vitro susceptibilities of Candida bloodstream isolates to the new triazole antifungal agents BMS-207147, Sch 56592, and voriconazoleM A Pfaller, S A Messer, R J Hollis, et al.
International Journal of Antimicrobial Agents|April 8, 2000
Trends in antimicrobial susceptibility of bacterial pathogens isolated from patients with bloodstream infections in the USA, Canada and Latin America. SENTRY Participants GroupD J Diekema, M A Pfaller, R N Jones, et al.
American Journal of Obstetrics and Gynecology|October 18, 2000
Group B streptococci causing neonatal bloodstream infection: antimicrobial susceptibility and serotyping results from SENTRY centers in the Western HemisphereJ I Andrews, D J Diekema, S K Hunter, et al.
Diagnostic Microbiology and Infectious Disease|August 1, 1988
Multicenter in vitro evaluation of lomefloxacin (NY-198, SC-47111), including tests against nearly 7,000 bacterial isolates and preliminary recommendations for susceptibility testingR N Jones, K E Aldridge, A L Barry, et al.
Journal of Clinical Microbiology|November 28, 2002
Molecular epidemiology of extended-spectrum beta-lactamase-producing, fluoroquinolone-resistant isolates of Klebsiella pneumoniae in TaiwanW-L Yu, R N Jones, R J Hollis, et al.
Pageof 55